☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
chronic kidney disease (CKD)
Ruud Dobber Shares Insights from RWE Data from the REVEAL-CKD Presented at the ERA-EDTA'23
September 26, 2023
AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Priority Review for Chronic Kidney Disease
January 6, 2021
Load more...
Back to Home
